# Effectiveness of an EHR Interface to Reduce Dosage of Hydroxychloroquine

> **NCT04310462** · NA · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 65 (actual)

## Conditions studied

- Rheumatic Diseases

## Interventions

- **OTHER:** New e-prescribing interface

## Key facts

- **NCT ID:** NCT04310462
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-01
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-02-28
- **Target enrollment:** 65 (ACTUAL)
- **Why stopped:** Study investigators became aware of an internal error that overrode randomization of providers; therefore, the study randomization for this study was no longer present.
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04310462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04310462, "Effectiveness of an EHR Interface to Reduce Dosage of Hydroxychloroquine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04310462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*